With Tuesday's launch of the Surface Pro 3 tablet, we have an answer: a slate that Microsoft insists is a viable replacement for your laptop. On the surface anyway ��I need to spend more time testing ��it appears that Microsoft might just be able to pull it off.
Microsoft defied some of the speculation leading up to Tuesday's event: that it would go small and compete against the iPad mini ��a battle that in all likelihood would leave Microsoft bloodied and beaten. Instead, Microsoft is fighting on a productivity-based playing field. Microsoft still expects to compete against Apple, of course, and not just against the iPad but against the company's popular MacBook Air notebook. Analyst Avi Greengart thinks it will also be competing against Windows-based Ultrabooks.
Hot Logistics Companies To Invest In Right Now: iShares U.S. Oil & Gas Exploration & Production ETF (IEO)
iShares Dow Jones U.S. Oil & Gas Exploration & Production Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Oil Exploration & Production Index (the Index). The Index measures the performance of the oil exploration and production sub-sector of the United States equity market. The Index includes companies that are engaged in the exploration for and extraction, production, refining and supply of oil and gas products.
The Fund will concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. Since all of the securities included in the Index are issued by companies in the oil exploration and production sub-sector, the Fund will be concentrated in the exploration and production industry. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By John Udovich]
At first glance, you might think it strange that we have both the ProShares UltraShort DJ-UBS Crude Oil ETF (NYSEARCA: SCO), a bearish bet on oil, and the iShares Dow Jones US Oil & Gas Ex Index ETF (NYSEARCA: IEO), a more bullish bet on both domestic oil and gas, in our SmallCap Network Elite Opportunity (SCN EO) portfolio. But there is a method to our apparent madness as one can be both bearish and bullish on oil and/or gas at the same time.
- [By Michael Burnick]
The big E&P (exploration and production) and major integrated oil stocks see profits rise and fall with the price of crude. The iShares US Oil & Gas Exploration & Production ETF (IEO) is one way to play this part of the oil patch.
- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some gas and oil stocks to your portfolio, the iShares Dow Jones U.S. Oil and Gas Exploration Index ETF (NYSEMKT: IEO ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this gas and oil ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The gas and oil ETF's expense ratio -- its annual fee -- is a relatively low 0.47%. The fund is on the small side, too, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in to this gas and oil ETF.
Best Managed Healthcare Stocks To Invest In 2015: MER Telemanagement Solutions Ltd.(MTSL)
Mer Telemanagement Solutions Ltd., together with its subsidiaries, designs, develops, markets, and supports a line of telecommunication expense management (TEM), and customer care and billing solutions for business organizations and other enterprises worldwide. Its TEM solutions assist enterprises and organizations in the allocation of costs, budget control, fraud detection, processing of payments, and spending forecasting. The company also offers converged billing solutions, including applications for charging and invoicing customers, interconnect billing, and partner revenue management through pre-pay and post-pay schemes for wireless providers, voice over Internet protocol, Internet protocol television, and content service providers. Its products provide telecommunication and information technology managers with tools to reduce communication costs, recover charges payable by third parties, and to detect and prevent abuse and misuse of telephone networks comprising fault telecommunication usage. The company markets its products through its direct sales force, distributors, and business telephone switching systems manufacturers and vendors. Mer Telemanagement Solutions Ltd. was founded in 1995 and is headquartered in Raanana, Israel.
Advisors' Opinion:- [By Monica Gerson]
MER Telemanagement Solutions (NASDAQ: MTSL) dropped 14.62% to $2.09 after the company terminated MVNE solution provider agreement with SBC Communications.
- [By James E. Brumley]
Trading can be a quirky game sometimes. Most of the time, news - or at least loudly voiced opinions - tend to result from or be the cause of a fast-moving stock. Every now and then though, as in the case with MER Telemanagement Solutions Ltd. (NASDAQ:MTSL), a stock can build up steam with little to no news linked to that move. That doesn't make that stock a poor pick, however. Indeed, MTSL looks like it's turning into a homerun, and that alone is worth a look.... and maybe even worth a shot.
- [By Bryan Murphy]
If you're a small cap enthusiast looking for some budding ideas, you may not need to look any further than China GengSheng Minerals, Inc. (NYSEMKT:CHGS), Bio Matrix Scientific Group Inc. (OTCMKTS:BMSN), and MER Telemanagement Solutions Ltd. (NASDAQ:MTSL). All three have either pushed themselves to the brink of a breakout, if they haven't started one already. Here's a closer technical look at MTSL, BMSN, and CHGS, and what it's going to take to get them going if they're not going already.
Best Managed Healthcare Stocks To Invest In 2015: Vulcan Materials Company(VMC)
Vulcan Materials Company engages in the production and sale of construction aggregates, as well as asphalt mix, ready-mixed concrete, and cement primarily in the United States. The company operates in four segments: Aggregates, Concrete, Asphalt Mix, and Cement. The Aggregates segment produces construction aggregates, which principally include crushed stone, sand, and gravel. Its aggregates are used in public and private sector construction projects, including highways, airports, water and sewer systems, industrial manufacturing facilities, and residential and nonresidential buildings, as well as railroad track ballast. The Concrete segment produces and sells ready-mixed concrete in California, Florida, Georgia, Maryland, Texas, Virginia, and the District of Columbia; and block and pre-cast beams, as well as resells purchased building materials for use with ready-mixed concrete and concrete block. The Asphalt Mix segment produces and sells asphalt mix in Arizona, Californi a, and Texas. The Cement segment produces and sells Portland and masonry cement in bulk and bags to the concrete products industry. This segment also imports cement, clinker, and slag to resell and export, as well as to blend, bag, or reprocess into specialty cements. In addition, this segment mines, produces, and sells calcium products for the animal feed, paint, plastics, water treatment, and joint compound industries. The company was formerly known as Virginia Holdco, Inc. and changed its name to Vulcan Materials Company in November 2007. Vulcan Materials Company was founded in 1909 and is headquartered in Birmingham, Alabama.
Advisors' Opinion:- [By Anna Prior]
Vulcan Materials Co.(VMC) said its board named J. Thomas Hill as the company’s new chief executive, succeeding Douglas James.
Weatherford International (WFT) PLC agreed to sell its land rig operations in Russia and Venezuela to Russia’s state-controlled oil giant Rosneft for $500 million in cash, as the oil-field services company continues to slim down and focus on its core businesses.
- [By Lu Wang]
Vulcan Materials Co. (VMC), an asphalt and cement supplier, is projected to return to profitability for the first time since 2009, according to analysts��estimates compiled by Bloomberg. Federal spending on highway construction has risen 11 percent this year, reaching the highest level since 2010, according to Bloomberg Industries research.
- [By Eric Volkman]
Vulcan Materials (NYSE: VMC ) has elected to maintain its dividend. The company declared a quarterly common stock distribution of $0.01 per share, to be paid on Sept. 10 to shareholders of record as of Aug. 28. That amount matches each of the company's disbursements stretching back to December 2011.
- [By Sean Williams]
Vulcan Materials (NYSE: VMC ) -- up 400%
Although its dividend boost came on none other than Valentine's Day, Vulcan's new $0.05 payout, a 400% increase over the $0.01 it had been paying out previously, still has a long way to go before it even gets remotely close to its pre-recession payout of $1.96 per year.
Best Managed Healthcare Stocks To Invest In 2015: PetMed Express Inc.(PETS)
PetMed Express, Inc., doing business as 1-800-PetMeds, operates a pet pharmacy in the United States. It markets non-prescription and prescription pet medications; and other health products for dogs and cats, as well as direct to consumers. The company?s non-prescription medications include flea and tick control products, bone and joint care products, vitamins and nutritional supplements, and hygiene products. Its prescription medications comprise heartworm preventatives; arthritis, thyroid, diabetes, and pain medications; antibiotics and other specialty medications; and generic substitutes. In addition, the company, through its Web site, 1800petmeds.com, sells beds, crates, stairs, strollers, and other pet supplies. PetMed Express offers its products under the Frontline Plus, K9 Advantix, Advantage, Heartgard Plus, Sentinel, Interceptor, Program, Revolution, Deramaxx, and Rimadyl brands. The company markets its products through national television, online, and direct mail /print advertising campaigns, as well as through telephone, catalogs, brochures, and postcards. It primarily serves retail customers. PetMed Express was founded in 1996 and is headquartered in Pompano Beach, Florida.
Advisors' Opinion:- [By Seth Jayson]
PetMed Express (Nasdaq: PETS ) is expected to report Q1 earnings around July 15. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict PetMed Express's revenues will grow 1.3% and EPS will increase 10.0%. - [By Peter Graham]
The Q1 2014 earnings report for pet supply retailer PetSmart, Inc (NASDAQ: PETM), a brick and mortar peer of online Petmed Express Inc (NASDAQ: PETS), is due out before the market opens on Wednesday. Aside from the PetSmart earnings report, it should be said that Petmed Express Inc reported�Q4 2013 earnings on May 5th (sales slipped 4.9% to $48.6 million while net income came in at $4.5 million�verses $4.6 million���results that were blamed on severe winter weather). However,�PetSmart did get some downgrades recently with analyst saying there is increased competition in the pets space.
Best Managed Healthcare Stocks To Invest In 2015: Portola Pharmaceuticals Inc (PTLA)
Portola Pharmaceuticals, Inc. (Portola), incorporated on September 2, 2003, is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.
Betrixaban
Portola's compound, betrixaban, is an oral, once-daily Factor Xa inhibitor being evaluated in the only biomarker-based Phase-III study for hospital to home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Betrixaban's properties particularly suited to potentially demonstrate efficacy without increasing bleeding in this patient population.
Andexanet Alfa
Portola's second development candidate, andexanet alfa (PRT4445), has the potential to be a reversal agent to directly reverse the effects of Factor Xa inhibitors in patients who suffer a bleeding episode or who require emergency surgery. Portola has entered into clinical collaboration agreements with all of the manufacturers of direct Factor Xa inhibitors, including Bristol-Myers Squibb and Pfizer (Eliquis [apixaban]), Bayer HealthCare and Janssen Pharmaceuticals (XARELTO [rivaroxaban]), and Daiichi Sankyo (Savaysa [edoxaban]), while retaining all decision-making and commercial rights to the program.
Cerdulatinib (PRT2070) and PRT2607
Portola's third wholly owned product candidate, cerdulatinib (PRT2070), is an orally available kinase inhibitor that uniquely inhibits two validated tumor proliferation pathways - spleen tyrosine kinase (Syk) and janus kinase (JAK). It is being studied in patients with leukemias or lymphomas with a focus on genetically-defined subtypes, as well as in patients who have failed therapy due to relapse or acquired mutations. Portola's fourth program is partnered with Biogen Idec and is focused on the development of PRT2607, a selective Syk inhibitor.
Advisors' Opinion:- [By Todd Campbell]
That leads me to Medivation (NASDAQ: MDVN ) , Ophthotech (NASDAQ: OPHT ) , and Portola (NASDAQ: PTLA ) , three companies with important therapies that may very well be destined to become top sellers.
No comments:
Post a Comment